UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.
Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...
Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results